Related Experiment Video

Updated: Nov 23, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.6K

Severe acute respiratory syndrome coronavirus 2-induced multisystem inflammatory syndrome in children

Zhiguan Feng1, Yanmin Bao1, Yonghong Yang1,2

  • 1Department of Respiratory Medicine Shenzhen Children's Hospital Shenzhen Guangdong China.

Pediatric Investigation
|December 30, 2020
PubMed

Insights

Multisystem inflammatory syndrome in children (MIS-C) caused by SARS-CoV-2 is a serious condition affecting multiple organs, often requiring intensive care. While treatment can lead to recovery, its long-term effects and causes require further investigation.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Immunology

Background:

  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can trigger multisystem inflammatory syndrome in children (MIS-C).
  • MIS-C is a critical condition impacting various organ systems, frequently necessitating intensive care unit admission.

Purpose of the Study:

  • To describe the clinical characteristics and outcomes of MIS-C.
  • To differentiate MIS-C from Kawasaki disease.
  • To highlight the need for further research into MIS-C pathophysiology and prognosis.

Main Methods:

  • Clinical case review and analysis.
  • Comparison of MIS-C features with Kawasaki disease.
  • Evaluation of treatment responses.

Main Results:

  • MIS-C presents with multi-organ involvement, distinct from Kawasaki disease, particularly in older children and adolescents.
  • Cardiovascular and gastrointestinal systems are frequently affected, with elevated inflammatory markers observed.
  • Immunomodulation therapy facilitates rapid and complete clinical recovery in most patients.

Conclusions:

  • MIS-C is a significant post-infectious complication of SARS-CoV-2 requiring prompt medical attention.
  • While recovery is often achieved with treatment, the underlying mechanisms and long-term outlook for MIS-C remain incompletely understood.
  • Further research is essential to elucidate MIS-C pathophysiology and long-term prognosis.

Keywords:
COVID‐19Kawasaki‐like diseaseMultisystem inflammatory syndrome in childrenSARS‐CoV‐2

More Related Videos

Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation11:07

Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation

Published on: July 6, 2019

26.0K
Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome04:45

Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome

Published on: June 2, 2022

2.6K

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
766
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
108
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
1.9K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
575
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
526
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.6K